CN(C)CCCOc1ccc(-c2cc3nc(NCc4cccnc4)n(C)c(=O)c3s2)cn1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?